Emerging multipotent aspects of hepatocyte growth factor.
about
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signalingMatriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivoHepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironmentDistribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissuesGenomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genesSustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growthHepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfatePhase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery diseaseNovel therapy for myocardial infarction: can HGF/Met be beneficial?Cross-talk between steroid-receptor-mediated and cell-membrane-receptor-mediated signalling pathways results in the in vivo modulation of c-Met and ornithine decarboxylase gene expression in mouse kidneyHepatocyte growth factor is a mitogen for olfactory ensheathing cellsViable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar developmentMicrotubule dynamics control HGF-induced lung endothelial barrier enhancementPaxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseTherapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications.Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells.Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium.Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytesNK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivoDisassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancerLiver zonation: Novel aspects of its regulation and its impact on homeostasis.hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure.Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.Using growth factor arrays and micropatterned co-cultures to induce hepatic differentiation of embryonic stem cellsPrinciples of liver regeneration and growth homeostasis.Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in MedulloblastomaHuman hepatocyte growth factor (hHGF)-modified hepatic oval cells improve liver transplant survivalHepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement.A pan-cancer analysis of alternative splicing events reveals novel tumor-associated splice variants of matriptase.Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation.Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.Therapeutic potentials occurring during the early differentiation process of mesenchymal stem cells in a rats model with thioacetamide-induced liver fibrosisRoles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.
P2860
Q24296700-15C95BB7-FD9B-4F0B-A4E4-AB51ABD838E7Q24672921-12161907-E057-442D-B322-23AA79E743EBQ28140022-F79D442F-8F38-48D3-AB3B-6AE263BC41FEQ28142489-C0001580-C300-4103-B166-09DE157A26FEQ28145050-8B6D3DA7-5FC8-471E-A349-E581D5CB062CQ28210078-B5B853EE-88D2-4222-B1F6-941DA663E7E4Q28257965-B6967A5B-4A77-46CB-A31E-61CED0550283Q28288230-3888523E-7A8C-4EBD-A6A8-14049E43D1C0Q28305555-07805228-2932-45D7-820A-4101F076AED1Q28345531-D957AB36-0205-4246-B91F-2B92C7639002Q28366555-56BC8C43-2059-4B65-A8E3-EFB165BF4244Q28507121-10ED74C5-10DF-4E0F-886E-D1B07EADD4E3Q28910357-7E6F203E-F41A-4F23-B587-E82379DFD39FQ30437439-D78FD364-41F4-485F-9904-2D5EED33B558Q30449821-206B8B5F-C340-4CF2-8FE6-B1D672D6C576Q30664734-CA90650D-7764-4978-BAEB-BBFA84ADCDBDQ30768542-B846CA09-ECC5-4673-8356-F337D36809DEQ30851343-E45749D1-FCBC-4D02-8106-9B2A4ACB96B8Q31099702-68665993-8C25-4585-B908-F9EE9EE1BAB7Q31963959-7E6F079C-AE80-4996-B370-68ABF68C63E4Q33236176-49CCB4E3-A374-468F-B4EA-DC9DAEC005DBQ33557290-64BEC7DA-CFF6-43E0-8BF4-35DB0B5AF76BQ33721862-D57150CF-1811-4D01-B753-B99F11F1AD5AQ33772210-A105C821-A1CB-47EA-82E3-6B7F7F34ED99Q33786959-649AB9F4-F8AC-4822-899A-26B6E2D63BBDQ33835771-7FB6E3CB-3E12-4D83-A819-D4ECD3EA7F08Q33868282-61237F74-E0D0-4753-88A2-160E567596B1Q33886995-AAAAEC49-3366-4B2D-B8FA-1061354464AEQ33889422-01979840-BD4E-4030-AD00-B9D369570687Q33913784-FED884F3-A9F0-4D5E-A6E6-16DC44DE743EQ34209343-44884C9C-49B2-4F08-B260-A0D7F9058679Q34347580-90735734-5526-43EC-A42F-8365E5DAE145Q34398276-249C5966-E8AB-448D-BF05-53BB2D8961D7Q34427464-C23E0F9D-F4E4-4BD5-9D4A-07ED062D23C8Q34560850-26E57A78-BFE2-4889-8783-26326A986964Q34655203-F8DA9D12-51C7-4D53-B96A-805573A7288AQ34712138-900C6096-3C61-484F-88D3-ACA6191D73B3Q34785157-41179A7E-67FB-463B-9485-4D1697363D81Q35006127-E165E23E-4F9F-4D45-8C5F-59F55726E7C8Q35062087-D3562C27-F187-4D98-A706-FBE50720296F
P2860
Emerging multipotent aspects of hepatocyte growth factor.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Emerging multipotent aspects of hepatocyte growth factor.
@en
type
label
Emerging multipotent aspects of hepatocyte growth factor.
@en
prefLabel
Emerging multipotent aspects of hepatocyte growth factor.
@en
P1476
Emerging multipotent aspects of hepatocyte growth factor.
@en
P2093
Matsumoto K
Nakamura T
P304
P356
10.1093/OXFORDJOURNALS.JBCHEM.A021283
P577
1996-04-01T00:00:00Z